MedPath

Comparison of safety and efficacy of two antifungal creams amorolfine and sertaconazole in treatment of superficial fungal infection (Tinea)

Phase 4
Conditions
Health Condition 1: null- Tinea cruris / corporis limited variety
Registration Number
CTRI/2014/12/005246
Lead Sponsor
Medical College Kolkata
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
66
Inclusion Criteria

•Untreated male and non-¬pregnant female patients above 18 years of age

•Acute, symptomatic tinea cruris/corporis with limited involvement i.e. limited to single body region

•KOH mount showing positive results (hyphae)

Exclusion Criteria

•Pregnant or nursing females

•Patients with diabetes mellitus, malignancy, renal or hepatic dysfunction

•Patients who received topical antifungal agents within the past week or received systemic antifungal agents within past four weeks.

•History of hypersensitivity to any of the study drugs

•Patients not willing to comply with protocol requirements

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical cureTimepoint: 2nd week,4th week and 6th week
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath